Approaches to discover latency-reversing agents

Approaches to discover latency-reversing agents

Bibliographic Details
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020313224

Similar Items

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
by: Shifei Li, et al.
Published: (2023-04-01)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016-07-01)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Latency Reversing Agents: Kick and Kill of HTLV-1?
by: Annika P. Schnell, et al.
Published: (2021-05-01)

Impact of latency‐reversing agents on human macrophage physiology
by: Laurent Hany, et al.
Published: (2023-01-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

Identification of a promising new class of latency reversing agents
by: A. Gramatica, et al.
Published: (2017-12-01)

Optimal Control of an HIV Model with Gene Therapy and Latency Reversing Agents
by: Zachary Abernathy, et al.
Published: (2021-11-01)

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo
by: R.M. Dunham, et al.
Published: (2017-12-01)

HIV latency reversing agents act through Tat post translational modifications
by: Georges Khoury, et al.
Published: (2018-05-01)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017-12-01)

Molecular Modeling and Synthesis of New HIV Latency-Reversing Agents Targeting the Lymphatic System
by: Beatriz Meduqui Rodrigues, et al.
Published: (2022-11-01)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
by: Rui Li, et al.
Published: (2023-01-01)

OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022-12-01)

HIV Latency Reversing Agents have diverse effects on Natural Killer Cell Function
by: Carolina Garrido, et al.
Published: (2016-09-01)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
by: Jared P. Taylor, et al.
Published: (2020-12-01)

Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood
by: S. Telwatte, et al.
Published: (2019-07-01)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
by: Michaela Madlenakova, et al.
Published: (2017-09-01)

Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.
by: Julie Boucau, et al.
Published: (2020-03-01)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.
by: Vipul Gupta, et al.
Published: (2018-02-01)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
by: Catherine A. Lewis, et al.
Published: (2023-07-01)

PP 2.13 – 00160 Enhancing Tolerability and Efficacy of Latency Reversing Agents in “Kick and Kill” HIV Cure Approaches
by: J. Moran, et al.
Published: (2022-12-01)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015-12-01)

Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells
by: J. Boucau, et al.
Published: (2015-12-01)

Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
by: D.A. Kulpa, et al.
Published: (2015-12-01)

A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
by: R. Ke, et al.
Published: (2015-12-01)

Discovering a New Okadaic Acid Derivative, a Potent HIV Latency Reversing Agent from <i>Prorocentrum lima</i> PL11: Isolation, Structural Modification, and Mechanistic Study
by: Dong Huang, et al.
Published: (2023-02-01)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
by: Thanarat Salahong, et al.
Published: (2021-05-01)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
by: Katherine M. Bricker, et al.
Published: (2021-08-01)

PP 5.4 – 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022-12-01)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen.
by: Hongbing Liu, et al.
Published: (2021-01-01)

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
by: Ignacio Relaño-Rodríguez, et al.
Published: (2019-05-01)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
by: Amina Ait-Ammar, et al.
Published: (2020-01-01)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016-05-01)

Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
by: Judith Grau-Expósito, et al.
Published: (2019-08-01)

Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?
by: Ramachandran Vignesh, et al.
Published: (2017-10-01)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
by: Sushant Khanal, et al.
Published: (2021-02-01)

Reanalysis of Gene Expression Profiles of CD4+ T Cells Treated with HIV-1 Latency Reversal Agents
by: Antonio Victor Campos Coelho, et al.
Published: (2020-09-01)

The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells
by: Dennis C. Copertino Jr., et al.
Published: (2023-09-01)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
by: Genevieve Tyndale Clutton, et al.
Published: (2018-06-01)